Inapill is developing 1st-in-class, oral small molecule therapeutics targeting immune cell metabolism (immunometabolism) for improved treatment of age-related chronic inflammatory and autoimmune disease. Recent honors: -Creative Destruction Lab Advanced Therapies Program - 2025-26 cohort -Californ... Read more
Org chart
Collapse
No reports!
Teams
This company has no teams yet
Offices
This company has no offices yet
